MWP
NVO

Meridian Wealth Partners’s Novo Nordisk NVO Stock Holding History

Meridian Wealth Partners’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-522
Closed -$18K – 867
2021
Q1 		$18K Buy
+522
New +$18.6K 0.01% 305

Other funds holding NVO

Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Fayez Sarofim & Co
Fayez Sarofim & Co Houston, Texas $39.1B AUM 15.14% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return
EHC
Everett Harris & Co Los Angeles, California $7.77B AUM 9.43% 1-Year Est. Return

Meridian Wealth Partners's NVO Position: Q2 2021 in Review

Meridian Wealth Partners sold out of Novo Nordisk (NVO) in Q2 2021, closing a stake of 522 shares — an estimated $18K sold.

Meridian Wealth Partners first reported a position in NVO in Q1 2021 and held it in 1 quarter. The position peaked at $18K in Q1 2021. 735 funds tracked by Wall St. Rank hold NVO as of Q2 2021.

  • Meridian Wealth Partners reported no remaining Novo Nordisk position as of Q2 2021 after selling out during the quarter.
  • Meridian Wealth Partners sold 522 Novo Nordisk shares in Q2 2021, an estimated $18K.
  • Meridian Wealth Partners first reported a position in Novo Nordisk in Q1 2021 and held it in 1 quarter.
  • Meridian Wealth Partners's Novo Nordisk position peaked at $18K in Q1 2021.
  • 735 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2021.

Based on Meridian Wealth Partners's 13F filing for Q2 2021, filed 12 Aug 2021.